Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    January 2017
  1. PLICHTA JK, Hughes K
    Radiation-Induced Angiosarcoma after Breast-Cancer Treatment.
    N Engl J Med. 2017;376:367.
    PubMed     Text format    


  2. DE GRAMONT A, Herrera A, de Gramont A
    Ribociclib for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2017;376:288.
    PubMed     Text format    


  3. ARAKI K, Miyoshi Y
    Ribociclib for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2017;376:288.
    PubMed     Text format    



  4. Ribociclib for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2017;376:289.
    PubMed     Text format    


  5. BRENTNALL AR, Duffy SW, Cuzick J
    Breast-Cancer Tumor Size and Screening Effectiveness.
    N Engl J Med. 2017;376:94.
    PubMed     Text format    



  6. Breast-Cancer Tumor Size and Screening Effectiveness.
    N Engl J Med. 2017;376:93-95.
    PubMed     Text format    


  7. KOPANS DB
    Breast-Cancer Tumor Size and Screening Effectiveness.
    N Engl J Med. 2017;376:93-4.
    PubMed     Text format    


  8. JATOI I, Anderson WF
    Breast-Cancer Tumor Size and Screening Effectiveness.
    N Engl J Med. 2017;376:93.
    PubMed     Text format    


    December 2016
  9. LYCETTE J
    Neglected - Cancer Care and Mental Health in Rural America.
    N Engl J Med. 2016;375:2220-2221.
    PubMed     Text format    


  10. BLOK EJ, van de Velde CJ, Smit VT
    70-Gene Signature in Early-Stage Breast Cancer.
    N Engl J Med. 2016;375:2199.
    PubMed     Text format    



  11. 70-Gene Signature in Early-Stage Breast Cancer.
    N Engl J Med. 2016;375:2199-2201.
    PubMed     Text format    


  12. THEWES B, Prins J, Friedlander M
    70-Gene Signature in Early-Stage Breast Cancer.
    N Engl J Med. 2016;375:2199-2200.
    PubMed     Text format    


    November 2016
  13. FINN RS, Martin M, Rugo HS, Jones S, et al
    Palbociclib and Letrozole in Advanced Breast Cancer.
    N Engl J Med. 2016;375:1925-1936.
    PubMed     Text format     Abstract available


  14. SHERR CJ
    A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6.
    N Engl J Med. 2016;375:1920-1923.
    PubMed     Text format    


  15. WOLFF AC
    CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard.
    N Engl J Med. 2016;375:1993-1994.
    PubMed     Text format    


    October 2016
  16. BUYSE M, Saad ED, Burzykowski T
    Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:1591-1594.
    PubMed     Text format    



  17. Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:1591-1594.
    PubMed     Text format    


  18. SANZ A, Del Valle ML
    Extending Adjuvant Aromatase-Inhibitor Therapy to 10 Years.
    N Engl J Med. 2016;375:1590-1591.
    PubMed     Text format    



  19. Extending Adjuvant Aromatase-Inhibitor Therapy to 10 Years.
    N Engl J Med. 2016;375:1590-1591.
    PubMed     Text format    


  20. HARRINGTON D, Parmigiani G
    Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:1593-4.
    PubMed     Text format    


  21. JOENSUU H
    Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:1592.
    PubMed     Text format    


  22. WELCH HG, Prorok PC, O'Malley AJ, Kramer BS, et al
    Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    N Engl J Med. 2016;375:1438-1447.
    PubMed     Text format     Abstract available


  23. HORTOBAGYI GN, Stemmer SM, Burris HA, Yap YS, et al
    Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  24. HUDIS CA, Dickler M
    Increasing Precision in Adjuvant Therapy for Breast Cancer.
    N Engl J Med. 2016;375:790-1.
    PubMed     Text format    


  25. CARDOSO F, van't Veer LJ, Bogaerts J, Slaets L, et al
    70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
    N Engl J Med. 2016;375:717-29.
    PubMed     Text format     Abstract available


  26. HUNTER DJ
    Uncertainty in the Era of Precision Medicine.
    N Engl J Med. 2016;375:711-3.
    PubMed     Text format    


    July 2016
  27. POLLARD JW
    Defining Metastatic Cell Latency.
    N Engl J Med. 2016;375:280-2.
    PubMed     Text format    


  28. GOSS PE, Ingle JN, Pritchard KI, Robert NJ, et al
    Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
    N Engl J Med. 2016;375:209-19.
    PubMed     Text format     Abstract available


  29. CAREY LA, Winer EP
    I-SPY 2--Toward More Rapid Progress in Breast Cancer Treatment.
    N Engl J Med. 2016;375:83-4.
    PubMed     Text format    


  30. RUGO HS, Olopade OI, DeMichele A, Yau C, et al
    Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
    N Engl J Med. 2016;375:23-34.
    PubMed     Text format     Abstract available


  31. PARK JW, Liu MC, Yee D, Yau C, et al
    Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:11-22.
    PubMed     Text format     Abstract available


    June 2016
  32. MACINNIS RJ, Pike MC, Hopper JL
    Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
    N Engl J Med. 2016;374:2403-4.
    PubMed     Text format    


  33. KARAM A
    Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
    N Engl J Med. 2016;374:2403.
    PubMed     Text format    


  34. HARTMANN LC, Lindor NM
    Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
    N Engl J Med. 2016;374:2404.
    PubMed     Text format    


  35. MENDELL JT
    Targeting a Long Noncoding RNA in Breast Cancer.
    N Engl J Med. 2016;374:2287-9.
    PubMed     Text format    


  36. CHLEBOWSKI RT, Budoff MJ
    Changing Adjuvant Breast-Cancer Therapy with a Signal for Prevention.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    April 2016
  37. MISRA M, Sagar P, Friedmann AM, Ryan DP, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 12-2016. An 8-Year-Old Boy with an Enlarging Mass in the Right Breast.
    N Engl J Med. 2016;374:1565-74.
    PubMed     Text format    


  38. FOUKAKIS T, Falato C, Bergh J
    A 21-Gene Expression Assay in Breast Cancer.
    N Engl J Med. 2016;374:1386-7.
    PubMed     Text format    


  39. DEBLED M, Tunon de Lara C, MacGrogran G
    A 21-Gene Expression Assay in Breast Cancer.
    N Engl J Med. 2016;374:1385-6.
    PubMed     Text format    


  40. SPARANO JA
    A 21-Gene Expression Assay in Breast Cancer.
    N Engl J Med. 2016;374:1387.
    PubMed     Text format    


    February 2016
  41. FOUAD TM
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:595.
    PubMed     Text format    


  42. EBY PR
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:595.
    PubMed     Text format    


  43. GAYLIS FD, Choi J, Kader AK
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:594-5.
    PubMed     Text format    


  44. WELCH HG, Gorski DH, Albertsen PC
    Trends in Metastatic Breast and Prostate Cancer.
    N Engl J Med. 2016;374:596.
    PubMed     Text format    


  45. HARTMANN LC, Lindor NM
    The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
    N Engl J Med. 2016;374:454-68.
    PubMed     Text format    


    January 2016
  46. MERRILL AL, Esserman L, Morrow M
    CLINICAL DECISIONS. Ductal Carcinoma In Situ.
    N Engl J Med. 2016;374:390-2.
    PubMed     Text format    


    November 2015
  47. URBAN C, Amoroso V, Spautz C
    Cavity Shave Margins in Breast Cancer.
    N Engl J Med. 2015;373:2186-8.
    PubMed     Text format     Abstract available


  48. BARTELINK H, Rutgers E, Wesseling J
    Cavity Shave Margins in Breast Cancer.
    N Engl J Med. 2015;373:2186-8.
    PubMed     Text format     Abstract available


  49. JIANG L, Jiang S, Long H
    Cavity Shave Margins in Breast Cancer.
    N Engl J Med. 2015;373:2186-8.
    PubMed     Text format     Abstract available



  50. Cavity Shave Margins in Breast Cancer.
    N Engl J Med. 2015;373:2186-8.
    PubMed     Text format     Abstract available



  51. Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer.
    N Engl J Med. 2015;373:1989.
    PubMed     Text format    


  52. MULLIEZ T, Veldeman L, De Neve W
    Regional Nodal Irradiation in Early-Stage Breast Cancer.
    N Engl J Med. 2015;373:1878.
    PubMed     Text format    


  53. HINDIE E, Groheux D
    Regional Nodal Irradiation in Early-Stage Breast Cancer.
    N Engl J Med. 2015;373:1877-8.
    PubMed     Text format    


  54. WHELAN TJ, Olivotto IA, Levine MN
    Regional Nodal Irradiation in Early-Stage Breast Cancer.
    N Engl J Med. 2015;373:1878-9.
    PubMed     Text format    


  55. POORTMANS PM, Struikmans H, Bartelink H
    Regional Nodal Irradiation in Early-Stage Breast Cancer.
    N Engl J Med. 2015;373:1879-80.
    PubMed     Text format    


    October 2015
  56. WELCH HG, Gorski DH, Albertsen PC
    Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
    N Engl J Med. 2015;373:1685-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: